DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetes

Por Fadini, Gian Paolo, Bonora, Benedetta Maria, Albiero, Mattia, Zaninotto, Martina, Plebani, Mario, Avogaro, Angelo
Publicado no Cardiovasc Diabetol (2017)

Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled tr...

Por Fadini, Gian Paolo, Bonora, Benedetta Maria, Zatti, Giancarlo, Vitturi, Nicola, Iori, Elisabetta, Marescotti, Maria Cristina, Albiero, Mattia, Avogaro, Angelo
Publicado no Cardiovasc Diabetol (2017)